Cancer Treatment Protocols Expert

About the role

The project supports the Syrian Ministry of Health in strengthening institutional capacity and governance. The Key Expert will provide strategic and technical assistance for developing, harmonising and implementing evidence‑based systemic anti‑cancer therapy protocols, with a focus on chemotherapy, medication safety, pharmacovigilance and clinical quality assurance.

Key responsibilities

• Develop, harmonise and adapt national systemic anti‑cancer therapy protocols, especially chemotherapy regimens, to the Syrian context.
• Facilitate consensus among clinical stakeholders on standardised, evidence‑based treatment pathways.
• Strengthen pharmacovigilance and medication‑safety systems for chemotherapy, including adverse‑event reporting and dose‑verification procedures.
• Design and deliver structured training programmes for oncology teams on protocol implementation, treatment sequencing and toxicity management.
• Create monitoring and evaluation tools to track treatment adherence, clinical outcomes and safety indicators across multiple oncology centres.

Required profile

• Medical degree with board certification or equivalent specialisation in Clinical Oncology, Medical Oncology, Haematology‑Oncology or Clinical Pharmacology.
• Minimum 10 years of clinical or technical experience in medical oncology, including protocol development or revision.
• Experience supporting ministries of health or national cancer‑control programmes in post‑conflict or early‑recovery settings is strongly preferred.
• Excellent written and spoken English; working knowledge of Arabic is a strong asset.

Required skills

• Chemotherapy protocol development and harmonisation.
• Pharmacovigilance and medication‑safety systems for oncology.
• Adaptation of international guidelines (WHO Essential Medicines List, NCCN, ESMO) to resource‑constrained health systems.
• Design of clinical training programmes for physicians, pharmacists and nursing staff.
• Monitoring and evaluation of protocol adherence and clinical outcomes.